Vice President Harris's urgent call to the DEA to expedite the rescheduling of cannabis marks a crucial turning point in national drug policy, as analyzed in a comprehensive equity research report byZuanic & Associates.

The report delves into the implications of Harris's push as well as theDepartment of Health and Human Services' (HHS) engagement with the Justice Department's Office of Legal Counsel on the complexities of altering cannabis's legal status.

In addition, senior analystPablo Zuanicaddresses critical industry questions, coveringFDAoversight, prescription criteria, insurance reimbursement, and the effects of legalization and rescheduling on...